Public Shell Firms Ramping Up Altcoin Buys Draws Skepticism: FT
Several public companies are exploring a new strategy: accumulating large holdings of altcoins to potentially boost their share prices. This mirrors the successful approach employed by MicroStrategy (MSTR), which has amassed a significant portion (2.9%) of all existing Bitcoin, resulting in over a 3,000% increase in its share price since 2020.
This Bitcoin treasury strategy has been replicated by other companies, with a recent trend involving Ether. However, the extension of this model to other altcoins has faced skepticism. Recent reports indicate that Avalanche is considering selling its AVAX tokens to a publicly-traded shell company to generate yield and attract investors. Similarly, RSV Capital aims to raise $200 million to invest in TON cryptocurrency through a shell company acquisition.
While some short-term gains have been observed, experts express concerns about the long-term viability of this strategy. For example, Charlie Lee’s $100 million investment in MEI Pharma to acquire Litecoin initially caused a 17% share price surge, but this was short-lived. The shares are now only slightly higher than before the announcement.
Financial analysts are highly critical of this approach. Eric Benoist of Natixis CIB labels it “hugely speculative,” arguing that the company’s value would ultimately be determined solely by the cryptocurrency’s worth on its balance sheet, offering no long-term security. Geoff Kendrick of Standard Chartered calls it “a flash in the pan,” highlighting the significant risk to both equity and bondholders should the altcoin’s price plummet. The potential for substantial losses emphasizes the inherent volatility and risk associated with this strategy, raising questions about its sustainability as a long-term investment approach for public companies. The short-term gains observed so far may not reflect the overall risk and potential for significant losses involved.
